 |
 |
 |
 |
 |
||||
 |
||||||||
|
instrumentation Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography solutions for the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. The company has developed patented technologies and a wide range of chromatographic products designed to significantly improve productivity by accelerating the separation, purification and analysis of molecules in bioanalysis. Cohesive's liquid chromatography technologies — including its multiplexing and TurboFlow systems— vastly increase sample throughput without sacrificing data quality, reliability, flexibility and ease of use, thereby accelerating the pace of customers' drug discovery and development efforts. (Exited December 2006 via sale to Thermo Fisher Scientific, Inc.)
Founded in 2000, Mauna Kea Technologies is specialized in the development of in vivo cellular imaging systems for biomedical applications. MKT has developed the world’s smallest microscope that is compatible with observations either on living animals for research applications or on patients for medical applications. Their goal is to provide researchers and clinicians with cellular imaging systems that will improve their daily practice, help them understand major pathologies and potentially diagnose them earlier.
Orthometrix, Inc., markets, sells and services several musculoskeletal product lines used in pharmaceutical research, diagnostic and monitoring of bone and muscle disorders, sports medicine, rehabilitative medicine, physical therapy and pain management. VersaMed Corporation has developed a next generation, computer-based
respiratory ventilator, the iVent201, which offers many advantages
over comparable mechanical ventilators. These include its small size
and portability, its flexible application in multiple clinical settings
(including transport and mobile), its ease of use and maintenance,
and its low cost (approximately 50% less than competing ventilators).
VersaMed offers its FDA-approved products to sub-acute, home care and
alternate care markets. (Exited March 2008 via sale to GE
Healthcare.)
|
|
||||||
 |
||||||||
 |
||||||||
|
||||||||
